N.A.K. Injection 20

Adult administration

Administer intravenously. The dosage should be appropriately adjusted by the physician based on the patient's age, weight, symptoms, and laboratory results. Fluid requirements for maintenance or replacement should be calculated for each patient based on these factors, and this medication should be administered accordingly. The rate of administration should not exceed 10 mEq per hour or 120 mEq per day based on potassium concentration. It is important to monitor blood glucose, serum electrolyte levels, and changes in fluid and electrolyte balance frequently during treatment.

This medication may cause allergic reactions, so if symptoms of hypersensitivity occur, use should be discontinued immediately and appropriate treatment should be obtained. Contains potassium; hence, patients with impaired kidney function or heart disease should be cautious as there is a risk of elevated blood potassium levels. Due to sodium and chloride content, blood sodium and chloride levels may increase, which could lead to fluid overload or edema; therefore, patients with related diseases should be careful. Additionally, this medication can induce hyponatremia, and special attention should be paid to children, the elderly, patients after surgery, and those taking certain medications, who should regularly check their blood sodium levels. It should be avoided in patients with fluid overload; if unavoidable, fluid balance and electrolyte status must be continuously monitored. Severe side effects can occur in case of overdose; therefore, administration doses and rates must be strictly managed. Interactions may occur when used with certain medications, so if taking medications, it is essential to inform your doctor or pharmacist. Safety during pregnancy has not been established; thus, it should only be used when absolutely necessary, and extra caution is warranted for children and the elderly. While using this medication, there is a possibility of side effects such as injection site infections, thrombosis, and phlebitis, so any abnormal symptoms should be reported to healthcare professionals immediately. Finally, this medication must be administered using sterile intravenous equipment, and the condition of the liquid must be carefully checked before and during administration.

Serious side effects

• Hypersensitivity reactions including anaphylaxis
• Hyperkalemia
• Hypernatremia, hyperchloremia
• Headaches and seizures due to hyponatremia
• Cardiac arrest
• Worsening of edema and congestive heart failure
• Pulmonary congestion and pulmonary edema due to fluid overload

Mild side effects

• Injection site infection
• venous thrombosis
• phlebitis
• extravasation
• fluid overload
• local pain
• venous irritation
• nausea
• vomiting
• abdominal pain

Store this medication in a sealed container to prevent air and moisture from entering. This helps maintain the effectiveness of the medication for an extended period and prevents deterioration.

Appearance

Colorless transparent liquid in a polypropylene, multi-layer film plastic container

Package unit

1000mL/pack